Alnylam Pharmaceuticals Inc <ALNY.O>: Truist Securities cuts target price to $315 from $410
ALNY•Related News
Nasdaq trade halt continues <PLTS.O> reason not available at 11:48 AM
PLTS•
Ames National director Michelle R Cassabaum acquires $4,228 of common shares
ATLO•
Oil prices drop 5% to three-week low after Trump cancels attack on Iran
XLE•
Delixy Holdings director Ye Changkun files initial beneficial ownership statement
DLXY•
Kennedy Lewis Capital Co Says Aggregate NAV $749.88 Mln, Portfolio Fair Value $1.11 Bln As Of June 30
KLC•